Clinical Trial Update: Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of mesenchymal and C-kit+ cardiac stem cells for regenerative therapy in ischemic cardiomyopathy has completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischaemic Cardiomyopathy

Drugs mentioned

• C-kit+ cardiac stem cells (C-kit+ cardiac stem cells)
• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Ischemic Cardiomyopathy | Phase 2 | Status: COMPLETED | Results posted: 2021-04-26